Clinical trial · Observational
Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Treatment Pattern, Clinical Outcome and Healthcare Resource Utilization Associated With Chinese Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP): A Retrospective Observational Study
NCT03509896CI-TRIAL-00059321completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Observational medical record review of newly diagnosed CML-CP participants in China
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Myeloid Leukemia | Chronic Myeloid Leukemia, BCR-ABL1 Positive | ALIAS | 0.90 |
| Chronic Myeloid Leukemia in Chronic Phase | — | UNRESOLVED | — |
| Philadelphia Chromosome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Non-Interventional | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Participants newly diagnosed with CML-CP
- interventionNames
- Other: Non-Interventional
Primary outcomes (5)
- measure
- Number of participants receiving each first-line treatment option
- timeFrame
- 2 years
- measure
- Number of participants with complete cytogenetic response
- timeFrame
- 2 years
- description
- Complete Cytogenetic Response (CCyR): 0% Ph+ cells in metaphase in bone marrow (BM)
- measure
- Number of participants with major molecular response (MMR)
- timeFrame
- 2 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Ph+ CML-CP patients who were diagnosed between August 1, 2014 to August 1, 2016 * 18 years or older at time of diagnosis Exclusion Criteria: * Participants once enrolled in any interventional clinical trial for CML * Participants whose records are not available Other protocol defined inclusion/exclusion criteria could apply
References
Publications (0)
Data not yet available
No reference posted for this study.